Update in palliative management of hormone refractory cancer of prostate.
Hormone refractory prostate cancer (HRPC) is an incurable disease and as in the pressure sensitive adhesive era the median survival of patients is increasing, these men increasingly develop symptomatic problems as a result of advanced local and or metastatic disease during their progression to death. Recently, it has been shown that it is possible to improve survival in this group of patients with use of chemotherapy which reinforces the need of better options in palliative care. We discus the various clinical problems (Part I) and treatment options of palliative care (Part II) and try to formulate an action plan in this review.
Singh
Pratipal
P
Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Srivastava
Aneesh
A
Cancer. 2004 Mar 1;100(5):892-9
14983482
Radiother Oncol. 1994 Apr;31(1):33-40
7518932
Radiology. 1989 Oct;173(1):225-9
2675185
J Clin Oncol. 2003 Apr 1;21(7):1232-7
12663709
J Neurosurg. 1983 Jul;59(1):111-8
6864265
J Urol. 2004 Apr;171(4):1525-8
15017212
Ann R Coll Surg Engl. 2003 Nov;85(6):382-5
14629877
Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):494-8
11914887
Prog Clin Biol Res. 1987;243B:479-85
2443925
J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68
12359855
Acta Chir Belg. 1998 Dec;98(6):255-60
9922813
Br J Urol. 1992 May;69(5):530-3
1320441
Urol Clin North Am. 1991 Feb;18(1):145-52
1992568
J Nucl Med. 1975 Nov;16(11):986-9
810549
Br J Urol. 1994 Nov;74(5):642-5
7827817
J Urol. 2002 Sep;168(3):1005-7
12187209
J Neurooncol. 1995;23(2):135-47
7543940
Prostate. 1997 May 15;31(3):153-60
9167766
Pharmacotherapy. 1999 Feb;19(2):223-7
10030773
Cancer. 1994 Nov 1;74(9):2516-9
7923009
Cancer. 1982 Sep 1;50(5):893-9
6178497
J Urol. 1976 Jul;116(1):1-7
778399
Urology. 1991 Dec;38(6):526-8
1746080
Br J Urol. 1994 Nov;74(5):559-65
7530118
Anesthesiology. 1996 May;84(5):1243-57
8624021
J Urol. 2001 Mar;165(3):871-5
11176489
J Urol. 1996 Aug;156(2 Pt 1):526-31
8683730
J Urol. 2001 Dec;166(6):2023-31
11696699
Br J Urol. 1992 Dec;70(6):643-7
1283104
Br J Urol. 1995 Jun;75(6):782-5
7613836
Radiother Oncol. 1986 Aug;6(4):247-55
3775071
Curr Probl Cancer. 1986 Mar;10(3):117-68
3514130
Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1281-5
2480941
Cancer. 1993 Feb 15;71(4):1309-12
8382106
Urology. 1986 Oct;28(4):280-7
3765236
Eur J Surg. 1994 Oct;160(10):535-42
7849154
N Engl J Med. 2004 Oct 7;351(15):1502-12
15470213
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
9362426
JAMA. 1995 Aug 2;274(5):420-4
7542352
Urology. 1974 May;3(5):562-4
4830631
J Urol. 2004 Feb;171(2 Pt 1):668-71
14713783
Eur Urol. 1993;24 Suppl 2:118-21
8262116
Ann Oncol. 2005 Apr;16(4):579-84
15734776
Md Med J. 1991 Feb;40(2):113-5
1997794
Urology. 1986 Nov;28(5):364-9
3787893
Qual Life Res. 2006 Oct;15(8):1297-306
16830258
Neuroscience. 2000;98(3):585-98
10869852
Semin Surg Oncol. 1995 Jan-Feb;11(1):50-9
7754276
J Urol. 1974 Jun;111(6):799-802
4830885
J Neurosurg. 1980 Dec;53(6):741-8
7441333
Scand J Urol Nephrol. 2001 Sep;35(4):288-94
11676354
Urol Clin North Am. 1999 May;26(2):375-89
10361560
J Pain Symptom Manage. 1992 Feb;7(2):110-6
1573284
Urology. 1997 Apr;49(4A Suppl):46-53
9111614
Curr Treat Options Neurol. 1999 Nov;1(5):409-416
11096725
J Urol. 2000 Oct;164(4):1248-53
10992374
Cancer. 1997 Feb 1;79(3):545-50
9028366